37 studies found for:    " May 30, 2012":" June 29, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting WelTel Retain: Promoting Engagement in Pre-ART HIV Care Through SMS
Condition: HIV
Intervention: Behavioral: WelTel SMS service
22 Terminated Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Lamivudine;   Drug: Tenofovir/Emtricitabine
23 Enrolling by invitation Minority AIDS Initiative Retention and Re-Engagement Project
Condition: HIV/AIDS
Intervention: Behavioral: Enhanced Peer Intervention
24 Completed Evaluation of Barriers to Postpartum Care in HIV Infected Women
Conditions: HIV Infection;   Pregnancy
Intervention: Other: questionaires and structured interviews
25 Completed A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTIs);   Drug: ritonavir;   Drug: saquinavir [Invirase]
26 Completed Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
Condition: HIV Infections
Intervention: Drug: FTC 200 mg/TDF 300 mg fixed-dose combination tablet
27 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: TUMS® Ultra Strength;   Drug: MINTOX® Maximum Strength
28 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
29 Recruiting Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya
Condition: Assisted-partner Notification Services
Intervention: Other: Assisted-partner notification services
30 Recruiting A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Etravirine;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Second line ART regimens are usually based on a boosted protease inhibitor (bPI) plus two nucleoside analogues (NRTIs);   Drug: Study provided drugs according to patient resistance profile (DRV, ETR, RTV, FTC/TDF) + any in country available drug as applicable & available;   Other: SOC adherence versus SOC+CPI adherence
31 Recruiting Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
Conditions: HIV-1 Infection;   Pf Subclinical Parasitemia
Interventions: Drug: Lopinavir/ritonavir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Efavirenz;   Drug: Nevirapine;   Drug: emtricitabine/tenofovir disoproxil fumarate;   Drug: trimethoprim/sulfamethoxazole
32 Unknown  The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Maraviroc (5 days);   Drug: Maraviroc and boceprevir (14 days)
33 Completed Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects
Condition: AIDS
Intervention: Procedure: Blood sample collection
34 Unknown  Randomized Control Trial on Trauma Focused CBT in Zambia
Conditions: Post Traumatic Stress Disorder;   Depression;   Risk Behaviors
Intervention: Behavioral: Trauma Focused Cognitive Behavioral Therapy
35 Completed Omega-3 Supplementation and Depression Clinical Trial
Condition: Depressive Symptoms
Interventions: Dietary Supplement: Soybean oil soft gels;   Dietary Supplement: Fish oil omega-3 EPA-rich soft gels
36 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Condition: Tuberculosis
37 Completed A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions
Condition: Healthy Participants
Interventions: Drug: darunavir;   Drug: cobicistat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years